Product Information
FOCALIN XR 30 MG CAPSULE is a brand product labeled by Sandoz Inc., priced at $4.7573 per EA under NDC 66758024031. Its NADAC has been published 24 times since Jan 14, 2026.
The High Outlier badge above means this manufacturer's average price in the dexmethylphenidate hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
30 mg/1
Manufacturer
Sandoz Inc.NDC
66758024031
Classification
Brand
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
DEXMETHYLPHENIDATE HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA021802On Market Since
5/31/2005
Pharmacological Classes
Price Statistics
The NADAC for FOCALIN XR 30 MG CAPSULE has been published 24 times since Jan 14, 2026, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.7573 per EA |
|---|---|
| All-time high | $4.7684 (Jun 10, 2026) |
| All-time low | $4.7317 (Jan 14, 2026) |
| 52-week high | $4.7684 |
| 52-week low | $4.7317 |
| Median price | $4.7317 |
| Average price | $4.7400 |
| Largest weekly change | +0.8% (May 20, 2026) |
| Weeks tracked | 24 |
| Tracking since | Jan 14, 2026 |
Generic Alternatives
The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 62% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of FOCALIN XR 30 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for FOCALIN XR 30 MG CAPSULE, manufactured by Sandoz Inc., is $4.7573 per EA (NDC 66758024031), effective Jun 24, 2026.
How has the price of FOCALIN XR 30 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for FOCALIN XR 30 MG CAPSULE has held within roughly two percent of its current level. It has been tracked across 24 weekly CMS publications since Jan 14, 2026.
What are the highest and lowest recorded NADAC prices for FOCALIN XR 30 MG CAPSULE?
Since Jan 14, 2026, the NADAC for FOCALIN XR 30 MG CAPSULE has ranged from a low of $4.7317 (Jan 14, 2026) to a high of $4.7684 (Jun 10, 2026), with a median of $4.7317 per EA.
Are there cheaper alternatives to FOCALIN XR 30 MG CAPSULE?
Yes. 4 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, DEXMETHYLPHENIDATE ER 30 MG CP, is $1.7969 per EA — about 62% below FOCALIN XR 30 MG CAPSULE.
Who manufactures FOCALIN XR 30 MG CAPSULE?
FOCALIN XR 30 MG CAPSULE (NDC 66758024031) is labeled by Sandoz Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification